Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ILMN – Illumina, Inc.

Illumina, Inc.
ILMN
$94.66
Name : Illumina, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $14,984,678,400.00
EPSttm : 7.9
finviz dynamic chart for ILMN
Illumina, Inc.
$94.66
7.84%
$8.05

Float Short %

5.14

Margin Of Safety %

-22

Put/Call OI Ratio

0.26

EPS Next Q Diff

0.11

EPS Last/This Y

11.93

EPS This/Next Y

0.41

Price

94.66

Target Price

112.1

Analyst Recom

2.42

Performance Q

23.72

Relative Volume

2.08

Beta

1.38

Ticker: ILMN




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04ILMN100.710.230.5179993
2025-07-07ILMN97.330.221.4778557
2025-07-08ILMN99.270.231.9479744
2025-07-09ILMN97.490.240.7680242
2025-07-10ILMN100.10.240.7180241
2025-07-11ILMN99.260.251.6781203
2025-07-14ILMN98.710.240.7579566
2025-07-15ILMN97.170.240.7079949
2025-07-16ILMN96.960.240.6180140
2025-07-17ILMN97.930.260.2080300
2025-07-18ILMN96.190.250.8781197
2025-07-21ILMN95.030.400.0252188
2025-07-22ILMN102.050.260.1973240
2025-07-23ILMN104.610.250.3174681
2025-07-24ILMN107.60.260.8675214
2025-07-25ILMN109.330.270.1776695
2025-07-28ILMN109.90.261.8774818
2025-07-29ILMN108.690.261.0675263
2025-07-30ILMN106.720.271.2975710
2025-07-31ILMN102.730.270.1776188
2025-08-01ILMN94.650.260.5792327
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04ILMN100.80181.31702.74.23
2025-07-07ILMN97.12181.31668.04.23
2025-07-08ILMN99.27181.31717.24.23
2025-07-09ILMN97.44181.31683.34.23
2025-07-10ILMN100.05181.31721.44.23
2025-07-11ILMN99.25181.31714.54.23
2025-07-14ILMN98.53181.31692.84.23
2025-07-15ILMN97.15181.31687.14.23
2025-07-16ILMN96.97181.31697.34.23
2025-07-17ILMN97.93181.31707.34.23
2025-07-18ILMN96.15181.31683.54.23
2025-07-21ILMN94.78181.31686.94.23
2025-07-22ILMN102.03181.31763.14.23
2025-07-23ILMN104.61181.31720.34.23
2025-07-24ILMN107.64180.91723.44.24
2025-07-25ILMN109.30180.91712.04.24
2025-07-28ILMN109.90180.91703.64.24
2025-07-29ILMN108.71180.91689.84.24
2025-07-30ILMN106.66180.91682.84.24
2025-07-31ILMN102.71180.91667.44.24
2025-08-01ILMN94.66180.91632.54.24
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04ILMN0.401.244.10
2025-07-07ILMN0.401.274.10
2025-07-08ILMN0.401.274.10
2025-07-09ILMN0.401.274.10
2025-07-10ILMN0.401.274.10
2025-07-11ILMN0.401.274.55
2025-07-14ILMN0.401.504.55
2025-07-15ILMN0.401.504.55
2025-07-16ILMN0.401.504.55
2025-07-17ILMN0.401.504.55
2025-07-18ILMN0.401.504.55
2025-07-21ILMN0.401.124.55
2025-07-22ILMN0.401.124.55
2025-07-23ILMN0.401.124.55
2025-07-24ILMN0.401.124.55
2025-07-25ILMN0.401.125.14
2025-07-28ILMN0.400.935.14
2025-07-29ILMN0.400.935.14
2025-07-30ILMN0.400.935.14
2025-07-31ILMN0.400.935.14
2025-08-01ILMN0.400.935.14
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.97

Avg. EPS Est. Current Quarter

1.01

Avg. EPS Est. Next Quarter

1.08

Insider Transactions

0.4

Institutional Transactions

0.93

Beta

1.38

Average Sales Estimate Current Quarter

1048

Average Sales Estimate Next Quarter

1055

Fair Value

73.96

Quality Score

40

Growth Score

33

Sentiment Score

50

Actual DrawDown %

82.5

Max Drawdown 5-Year %

-86.2

Target Price

112.1

P/E

11.99

Forward P/E

19.74

PEG

1.23

P/S

3.5

P/B

6.36

P/Free Cash Flow

17.11

EPS

7.9

Average EPS Est. Cur. Y​

4.24

EPS Next Y. (Est.)

4.65

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

29.37

Relative Volume

2.08

Return on Equity vs Sector %

-64.5

Return on Equity vs Industry %

-51.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

1632.5
Illumina, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 8970
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
stock quote shares ILMN – Illumina, Inc. Stock Price stock today
news today ILMN – Illumina, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ILMN – Illumina, Inc. yahoo finance google finance
stock history ILMN – Illumina, Inc. invest stock market
stock prices ILMN premarket after hours
ticker ILMN fair value insiders trading